Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases

SM Lagoumtzi, N Chondrogianni - Free Radical Biology and Medicine, 2021 - Elsevier
Cellular senescence is a heterogeneous process guided by genetic, epigenetic and
environmental factors, characterizing many types of somatic cells. It has been suggested as …

[HTML][HTML] Epigenetics in cancer stem cells

TB Toh, JJ Lim, EKH Chow - Molecular cancer, 2017 - Springer
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of
cells commonly termed “cancer stem cells” that has been proposed to be a strong driving …

Molecular mechanisms of apoptosis and roles in cancer development and treatment

S Goldar, MS Khaniani, SM Derakhshan… - Asian Pacific journal …, 2015 - koreascience.kr
Programmed cell death (PCD) or apoptosis is a mechanism which is crucial for all
multicellular organisms to control cell proliferation and maintain tissue homeostasis as well …

[HTML][HTML] Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents

M Mottamal, S Zheng, TL Huang, G Wang - Molecules, 2015 - mdpi.com
Histone dacetylases (HDACs) are a group of enzymes that remove acetyl groups from
histones and regulate expression of tumor suppressor genes. They are implicated in many …

[HTML][HTML] New and emerging HDAC inhibitors for cancer treatment

AC West, RW Johnstone - The Journal of clinical …, 2014 - Am Soc Clin Investig
Epigenetic enzymes are often dysregulated in human tumors through mutation, altered
expression, or inappropriate recruitment to certain loci. The identification of these enzymes …

Sp1 and the 'hallmarks of cancer'

K Beishline, J Azizkhan‐Clifford - The FEBS journal, 2015 - Wiley Online Library
For many years, transcription factor Sp1 was viewed as a basal transcription factor and
relegated to a role in the regulation of so‐called housekeeping genes. Identification of Sp1's …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …

[HTML][HTML] Epigenetic mechanisms and the hallmarks of cancer: An intimate affair

N Darwiche - American journal of cancer research, 2020 - ncbi.nlm.nih.gov
Epigenetic mechanisms comprising DNA methylation, histone modifications, and noncoding
RNAs affect chromatin structure and regulate gene expression. These mechanisms control …

Histone deacetylases and cancer

MA Glozak, E Seto - Oncogene, 2007 - nature.com
Histone deacetylases (HDACs) regulate the expression and activity of numerous proteins
involved in both cancer initiation and cancer progression. By removal of acetyl groups from …

Epigenetic therapy of cancer: past, present and future

CB Yoo, PA Jones - Nature reviews Drug discovery, 2006 - nature.com
The initiation and progression of cancer is controlled by both genetic and epigenetic events.
Unlike genetic alterations, which are almost impossible to reverse, epigenetic aberrations …